ArticlePloS one2022

Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial).

José Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.